Navigation Links
Commonly-prescribed drugs may influence the onset and progression of Alzheimer's disease
Date:6/12/2013

Multiple drug classes commonly prescribed for common medical conditions are capable of influencing the onset and progression of Alzheimer's disease, according to researchers at The Mount Sinai Medical Center. The findings are published online in the journal PLoS One.

Led by Giulio Maria Pasinetti, MD, PhD, the Saunders Family Chair and Professor in Neurology at Mount Sinai, a research team used a computer algorithm to screen 1,600 commercially-available medications to assess their impact on the brain accumulation of beta-amyloid, a protein abnormally accumulated in the brain of Alzheimer's disease and implicated in neurodegeneration. They found that currently-available medications prescribed for conditions such as hypertension, depression, and insomnia were found to either to block or to enhance the accumulation of beta-amyloid, the component of amyloid plaques.

"This line of investigation will soon lead to the identification of common medications that might potentially trigger conditions associated with the prevention, or conversely the onset, of Alzheimer's disease," said Dr. Pasinetti. "They may be a novel reference for physicians to consider when prescribing the most appropriate drug, particularly in subjects at high risk for Alzheimer's disease."

To validate the screening protocol, Dr. Pasinetti and his colleagues administered these drugs in mice that were genetically engineered to develop the hallmark amyloid plaques associated with Alzheimer's disease. After six months of treatment with blood pressure medicines, amyloid plaques and neurodegeneration were significantly reduced in the mice. One such medicine was Carvedilol, now under clinical investigation in Alzheimer 's disease with the intent to slow down memory deterioration.

"In recent years, amyloid plaques have become one of the main focal points in the search to understand and to treat Alzheimer's disease," said Dr. Pasinetti. "Thus, identifying novel dr
'/>"/>

Contact: Mount Sinai Press Office
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Pharmacy Robots Linked to Bacterial Contamination of Drugs
2. Penn study cautions use of drugs to block niacin flush
3. Urinary Incontinence Drugs May Be More Trouble Than Theyre Worth
4. Discovery could help to develop drugs for organ transplant and cancer patients
5. Not taking gastroprotective drugs prescribed with anti-inflammatory medicines
6. Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment
7. Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
8. Seniors Stop Taking Heart Drugs In Medicare Donut Hole
9. New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds
10. About 1 baby born each hour addicted to opiate drugs in U.S., U-M study shows
11. Blood pressure drugs linked with lower PTSD symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... MA (PRWEB) October 20, 2014 ... sponsoring a booth at the American Foundation for Suicide ... 25th. The AFSP is a not-for-profit organization that hosts ... Net proceeds from these events are used to help ... but education and personal relationships as well. , ...
(Date:10/20/2014)... October 20, 2014 hc1.com today ... secure cloud solution that enables healthcare organizations of ... ultimate healthcare-specific customer relationship management (“CRM”) solution. , ... unique needs of the healthcare industry, the hc1 ... providers and patients by combining healthcare CRM, HIPAA-compliant ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Principle Business ... takes pride in manufacturing top-of-the-line absorbent products. The ... of its most popular brand, Tranquility® Premium Protection absorbent ... a new website, gave its packaging a new look, ... the brand message to the public. , The new ...
(Date:10/20/2014)... 2014 Succeed is proud to announce that ... participated in the Every Body Walk! campaign by ... project that encourages workers to be more active outside of ... which concluded at the end of September, was a friendly ... metro areas. Participating companies gave their staff pedometers and ...
(Date:10/20/2014)... Ohio (PRWEB) October 20, 2014 Unveiled at ... new Strategic Direction Scorecard conservatively estimates member hospital ROI on ... spent on dues, The Center provides $12.50 in value to ... is (Member Value – Member Dues)/Member Dues. , “This ... at this number and we think the methodology is really ...
Breaking Medicine News(10 mins):Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4
... FORT LAUDERDALE, Fla., Dec. 10 Synovics,Pharmaceuticals, Inc. (OTC ... further reduction of its debt by paying off the,last ... the sale of,additional Series C Convertible Redeemable Preferred Stock ... As previously reported in the ...
... MIAMI, Dec. 10 Todobebe, Inc., a leading ... today the roll out,of its website property "embarazo.com", ... URL in 1999, and the new site reinforces ... trusted,content for Spanish speaking families globally. , ...
... LLC (Prime),announces that it has been chosen by Blue ... pharmacy benefit management services, beginning,January 1, 2009. , ... benefit services to more than 175,000 BCBSMT,members enrolled in ... covers a range of pharmacy benefit services including:,claims processing, ...
... to drive again , , WEDNESDAY, Dec. 10 (HealthDay News) -- ... after orthopedic surgery or injury, but knowing when it,s safe to ... surgeons weigh in on the issue in the December issue of ... "Deciding when a patient can return to driving is a difficult ...
... density, new analysis shows , , WEDNESDAY, Dec. 10 (HealthDay ... Actos, double the risk of fractures in women but ... Avandia (rosiglitazone) and Actos (pioglitazone) are used to lower ... studies have suggested that the risk for heart failure, ...
... Artist Toni Braxton and Her Son Featured in TV and ... YORK, Dec. 10 The Advertising Council, in partnership with ... of public service advertisements (PSAs) featuring Grammy award-winning recording artist ... about autism and to urge parents to learn the early ...
Cached Medicine News:Health News:Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt 2Health News:Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt 3Health News:Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt 4Health News:Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt 5Health News:Todobebe Rolls Out Embarazo.com for Pregnant Moms 2Health News:Prime Therapeutics Announces Blue Cross and Blue Shield of Montana as a Pharmacy Benefit Services Client 2Health News:Returning to the Road Tricky After Injury 2Health News:2 Diabetes Drugs Double Fracture Risk in Women 2Health News:2 Diabetes Drugs Double Fracture Risk in Women 3Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 2Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 3Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 4
(Date:10/17/2014)... DUBLIN , Oct. 17, 2014 ... of the "Research and Development Prospect of ... offering. Based on the 2013 ... Chinese government policies about dialysis industry and the ... in-depth research about dialysis industry segmentations. Moreover, it ...
(Date:10/17/2014)... Oct. 17, 2014 A victim of medical negligence ... doctor with a history of alcohol abuse, a physician ... on Prop 46 today, highlighting how Prop 46 will identify ... testing. The ad pictures a doctor drinking ... To ER."  Proposition 46 will enact the first law in ...
(Date:10/17/2014)...  Talyst, a market leader in pharmacy automation will ... Nashville, TN. The company will ... for onsite, remote medication dispensing. Talyst,s ... and securely dispense medication onsite, on demand. Remote dispensing ... that the correct medication gets to the correct patient ...
Breaking Medicine Technology:Research and Development Prospect of China Dialysis Market, 2014-2018 2Research and Development Prospect of China Dialysis Market, 2014-2018 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 2Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 4Talyst Exhibits at LeadingAge Annual Meeting 2
... 13, 2010 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ... third quarter of 2010 on Wednesday, October 20, 2010 at ... and chief executive officer, will lead the call. On the ... third quarter of 2010.   The call will ...
... Following recent FDA approvals for prostate cancer treatment ... the lives of men with advanced prostate cancer ... from Johnson & Johnson. The drug, which could reach the ... with the potential to change clinical practice by providing ...
Cached Medicine Technology:Amylin Pharmaceuticals to Webcast Third Quarter Results 2Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Treatment Drug Abiraterone 2
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Used to introduce balloon, diagnostic and guiding catheters, or other devices for intervention....
Used to introduce large devices for vascular intervention....
Used to introduce balloon, closed and non-tapered end catheters and other devices for intervention....
Medicine Products: